About: Management of Secondary Hyperparathyroidism: Proceedings of an International Symposium on Secondary Hyperparathyroidism held by the Japanese Society for Parathyroid Intervention.

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Management of Secondary Hyperparathyroidism: Proceedings of an International Symposium on Secondary Hyperparathyroidism held by the Japanese Society for Parathyroid Intervention. Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/oup/periodical/ndt/2003/volume_18
Title	Management of Secondary Hyperparathyroidism: Proceedings of an International Symposium on Secondary Hyperparathyroidism held by the Japanese Society for Parathyroid Intervention.
has manifestation of work	http://hub.abes.fr/oup/periodical/ndt/2003/volume_18/issue_suppl3/m/print http://hub.abes.fr/oup/periodical/ndt/2003/volume_18/issue_suppl3/m/web
Date Copyrighted	2003
Rights	European Renal Association-European Dialysis and Transplant Association European Renal Association–European Dialysis and Transplant Association
issue	suppl_3
is Is Part Of of	Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography Percutaneous calcitriol injection therapy (PCIT) for secondary hyperparathyroidism: multicentre trial Ultrasonographic diagnosis of parathyroid glands and percutaneous ethanol injection therapy Evaluation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology Role of parathyroid intervention in the management of secondary hyperparathyroidism Combined radioguided parathyroidectomy and intravenous vitamin D therapy for the treatment of uraemic hyperparathyroidism Molecular targets of hyperphosphataemia in chronic renal failure Introduction Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients Long-term prognosis of parathyroid function for chronic dialysis patients after minimally invasive radioguided parathyroidectomy (MIRP) Medical management of secondary hyperparathyroidism in chronic renal failure Adenovirus-mediated functional gene transfer into parathyroid cells in vivo and in vitro Time course of change in calcium × phosphorus product after percutaneous ethanol injection therapy Control of parathyroid cell growth by calcimimetics Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27 Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients Role of osteoclastic dysfunction in the development of renal bone disease Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients Colestimide can be used as a phosphate binder to treat uraemia in end-stage renal disease patients

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata